The Discovery & Development Europe 2025 focuses on guiding biopharma from target identification to clinical candidate, with strategies to optimize early R&D and accelerate drug development.
Topics
Scientific and technical case studies on best practices across the R&D pipeline
Spotlights on novel targets, including innovative biologics and small molecules beyond RO5
Formulation and delivery bottleneck identification and resolution
Deep dives into unmet disease areas, with a focus on neuroscience
Automation and AI for improving lab productivity in R&D
Strategies for accelerating target identification to clinical candidate development
Balancing safety, efficacy, and innovation in drug development
Who should Attend
R&D scientists and biopharma researchers
Drug development professionals
Biopharma leaders and executives
Formulation and delivery experts
Biomedical engineers focused on lab productivity
Professionals interested in automation and AI in R&D
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.By clicking "Accept", you consent to our use of cookies. You can manage your preferences or learn more by clicking "Customize" or visiting our Cookies Policy page.
